Trials / Completed
CompletedNCT02602470
Preferences & Treatment Satisfaction Drivers in Rosacea Patients
A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 206 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) | Azelaic Acid Gel 15%, Azelaic Acid Gel 15% w/Cleanser \& Moisturizing |
| DRUG | Azelaic Acid Cream | Azelaic Acid Cream 20% |
| DRUG | Metronidazole gel | Metronidazole Gel 1%, Metronidazole Gel 1% w/ Cleanser, Metronidazole Gel 0.75%, Metronidazole Gel 0.75% w/ Cleanser |
| DRUG | Metronidazole cream | Metronidazole Cream 1%, Metronidazole Cream 0.75%, Metronidazole Cream 0.75% w/ Cleanser |
| DRUG | Metronidazole Emulsion | Metronidazole Emulsion 0.75% |
| DRUG | Metronidazole Lotion | Metronidazole Lotion 0,75% |
| DRUG | Brimonidine Tartrate Gel | Brimonidine Tartrate Gel 0.33% |
Timeline
- Start date
- 2015-01-08
- Primary completion
- 2016-03-10
- Completion
- 2016-03-10
- First posted
- 2015-11-11
- Last updated
- 2020-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02602470. Inclusion in this directory is not an endorsement.